Statistics
Publications
12
Citations
534
H-Index
10
Active since
2016
Fengtian Li is an author at Sichuan University specializing in oncology, molecular oncology, and cancer cell signaling.
Publications per year
2016–2025
12
12
FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth
Mengmeng Niu, Jing Xu, Yang Liu et al. · Nature Communications · 2021 · 63 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 12